Seeking Alpha

Roche (RHHBY.OB): Q1 sales +5.1% to 11.6B Swiss francs ($12.4B), above consensus of 11.5B...

Roche (RHHBY.OB): Q1 sales +5.1% to 11.6B Swiss francs ($12.4B), above consensus of 11.5B francs. Pharmaceuticals sales +7% to 9.2B francs, diagnostics +1% to 2.4B francs; Herceptin (breast cancer) 1.57B francs; Tamiflu +84% to 335M francs, due to severe flu season in U.S. Reiterates that 2013 sales will rise at same rate as in 2012, while core EPS will increase faster than revenues. (PR)

Check out Seeking Alpha’s new Earnings Center »

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs